| Product Name | MF | CAS | Details |
|---|
| MARK-IN-2 | C18H18ClF2N5OS | 1314893-26-9 | Details |
| Pparδ agonist 1 | C26H27NO5 | 1902161-12-9 | Details |
| PHT-7.3 | C24H23N3O3S | 1614225-93-2 | Details |
| Epelsiban | C30H38N4O4 | 872599-83-2 | Details |
| Kgp-IN-1 | C19H24F4N4O3 | 2097865-36-4 | Details |
| DYRKs-IN-2 | C32H38ClN9O3 | 1386980-04-6 | Details |
| PERK-IN-3 | C22H16F2N4O2 | 1337532-08-7 | Details |
| (R)-MIK665 | C47H44ClFN6O6S | 1799831-02-9 | Details |
| LY88074 Trimethyl ether | C24H20O4S | 63675-87-6 | Details |
| Etamicastat | C14H15F2N3OS | 760173-05-5 | Details |
| RIPK1-IN-3 | C22H19F3N6O3 | 2242677-36-5 | Details |
| Dacarbazine citrate | C12H18N6O8 | 64038-56-8 | Details |
| ROR agonist-1 | C21H20F6N2O5S | 2361528-74-5 | Details |
| QPX7728 methoxy acetoxy methy ester | C14H14BFO7 | 2170834-57-6 | Details |
| FXIa-IN-1 | C20H19F3N4O5 | 1803271-50-2 | Details |
| GPR35 agonist 1 | C10H4BrN5O5 | 2079880-92-3 | Details |
| Dacarbazine hydrochloride | C6H11ClN6O | 17925-90-5 | Details |
| GSK1521498 free base (hydrochloride) | C24H21ClF2N4 | 1007578-24-6 | Details |
| hDDAH-1-IN-1 | C8H20N4O | 1229238-69-0 | Details |
| DS88790512 | C22H29N3O2 | 2231089-95-3 | Details |
| Menin-MLL inhibitor 4 | C32H38FN7O3 | 2169916-13-4 | Details |
| KDM4-IN-2 | C25H26N6O | 2369607-62-3 | Details |
| OT antagonist 3 | C21H20N6O2 | 925703-75-9 | Details |
| 6751-0002 | C17H12ClNO3 | 51505-10-3 | Details |
| GNE-616 | C24H23F4N5O3S | 2349371-81-7 | Details |
| Norverapamil-d7 | C26H29D7N2O4 | 263175-44-6 | Details |
| IDO1 and HDAC1 Inhibitor | C25H22BrFN8O4 | 2227044-16-6 | Details |
| HS79 | C19H22N4S | 2138838-56-7 | Details |
| FGFR4-IN-4 | C28H32Cl2N6O5 | 2230973-67-6 | Details |
| DC41 | C37H34ClN5O4S | 1354787-69-1 | Details |
| OTS186935 trihydrochloride | C25H27Cl2N5O2 | 2093401-85-3 | Details |
| Mcl1-IN-4 | C28H26N2O5S | 1580484-04-3 | Details |
| HL271 | C13H17ClF3N5O | 1422365-52-3 | Details |
| MBM-17S | C32H34N6O6 | 2083621-91-2 | Details |
| EML741 | C31H49N5O2 | 2328074-38-8 | Details |
| FM26 | C22H15ClF3N3O3 | 2407981-35-3 | Details |
| Blonanserin HCl | C23H31ClFN3 | 132812-45-4 | Details |
| IDO/TDO-IN-1 | C25H24FN5 | 2033173-01-0 | Details |
| Kv3 modulator 3 | C19H18N4O3 | 1498186-01-8 | Details |
| RAF mutant-IN-1 | C23H17Cl2FN6O2S | 2340020-82-6 | Details |
| IV-23 | C18H18BrNO4 | 2326007-49-0 | Details |
| hDDAH-1-IN-2 | C8H20N4O2 | 2408834-77-3 | Details |
| PF-06726304 acetate | C24H25Cl2N3O5 | 2080306-28-9 | Details |
| KRAS inhibitor-4 | C30H39ClN8O | 2374152-69-7 | Details |
| MAGL-IN-1 | C22H24FNO3 | 2324160-91-8 | Details |
| MCB-3681 | C31H32F2N4O8 | 790704-42-6 | Details |
| MTH1-IN-2 | C24H27N3O5S | 901044-91-5 | Details |
| Kv3 modulator 2 | C21H21N3O4 | 2101321-76-8 | Details |
| RP-001 hydrochloride | C24H25ClN4O4 | 1781880-34-9 | Details |
| ELN318463 | C19H20BrClN2O3S | 851600-86-7 | Details |
| OT antagonist 1 | C22H22N4O3 | 479080-38-1 | Details |
| Prolyl Hydroxylase inhibitor 1 | C19H18ClN5O4 | 2205125-60-4 | Details |
| DIQ3 | C23H15N5 | 2258636-02-9 | Details |
| ERK2 IN-1 | C36H34FN7O2S | 1093061-47-2 | Details |
| RORγt Inverse agonist 3 | C29H31Cl2N5O4S | 2364429-77-4 | Details |
| FAAH-IN-1 | C20H19ClN4OS | 1242441-47-9 | Details |
| MARK-IN-1 | C22H23F2N7OS | 1109283-93-3 | Details |
| HAT-IN-1 | C23H18BrF4N3O4 | 1889281-94-0 | Details |
| MK-7145 | C26H30N2O6 | 1255204-84-2 | Details |
| ML218 hydrochloride | C19H27Cl3N2O | 2319922-08-0 | Details |
| PI3K-IN-9 | C19H23N7O | 2360875-63-2 | Details |
| Glucokinase activator 1 | C27H20F2N2O7S2 | 1328987-85-4 | Details |
| QPX7728-OH disodium | C10H6BFNaO5- | 2170848-99-2 | Details |
| FadD32 Inhibitor-1 | C24H20ClN3O | 2081969-24-4 | Details |
| HS80 | C19H22N4S | 2138838-57-8 | Details |
| GSK2973980A | C25H19F5N4O4 | 2219321-25-0 | Details |
| EGFR-IN-1 | C28H30N6O4 | 1625677-63-5 | Details |
| Lp-PLA2-IN-2 | C19H23FN2O4S | 2071636-15-0 | Details |
| P-gp modulator 1 | C41H72N2O6 | 2249749-39-9 | Details |
| Ribocil-C Racemate | C21H21N7OS | 2309762-18-1 | Details |
| (Rac)-BL-918 | C23H15F8N3OS | 2435589-07-2 | Details |
| Ebopiprant | C30H34FN3O5S2 | 2005486-31-5 | Details |
| GSK 690 Hydrochloride | C24H23N3O.ClH | 2436760-79-9 | Details |
| IRAK4-IN-6 | C25H32N10O2 | 2454244-02-9 | Details |
| NSC 601980 | C15H12N4 | 2070018-27-6 | Details |
| GNE684 | C23 H24 N6 O3 | 2438637-64-8 | Details |
| NPD-1335 | C28H29N3O3 | 2376326-31-5 | Details |
| Kv3 modulator 1 | C20H20N4O4 | 1380696-64-9 | Details |
| (Rac)-AMG8379 | C25H16ClF2N3O5S | 1641574-26-6 | Details |
| RIP2 Kinase Inhibitor 3 | C19H24N4O3S | 1398053-50-3 | Details |
| LpxH-IN-AZ1 | C21H22F3N3O3S | 901260-40-0 | Details |
| EGFR-IN-1 hydrochloride | C28H31ClN6O4 | 2227455-78-7 | Details |
| PD-1-IN-22 | C25H25N5O4 | 2349372-98-9 | Details |
| OMDM-6 | C28H42N2O3 | 616884-67-4 | Details |
| DB1976 | C20H16N8Se | 1557397-51-9 | Details |
| NUCC-390 | C23H33N5O | 1060524-97-1 | Details |
| DAGLβ-IN-1 | C28H34F3N5O4 | 1402612-61-6 | Details |
| DHODH-IN-1 | C21H20F3N3O2 | 1800296-63-2 | Details |
| DHODH-IN-12 | C10H9N3O2 | 1263303-93-0 | Details |
| EG01377 2HCl | 2749438-61-5 | Details |
| Lp-PLA2-IN-3 | C20H13ClF3N3O3S | 2196245-16-4 | Details |
| DHODH-IN-4 | C17H12Cl2N2O2 | 1148125-93-2 | Details |
| hDHODH-IN-7 | C21H23FN4O | 1644156-41-1 | Details |
| GLPG1205 | C22H22N2O4 | 1445847-37-9 | Details |
| RAS GTPase inhibitor 1 | C27H28ClF4N5O2 | 2252242-32-1 | Details |
| IQB-782 | C4H9N3O2S | 40454-21-5 | Details |
| Dabuzalgron HCl | C12H17Cl2N3O3S | 219311-43-0 | Details |
| CMLD012612 | C31H33N3O7 | 2368900-35-8 | Details |
| CRS400393 | C18H20Cl2N2OS | 2253175-64-1 | Details |
| CWHM-1552 | C22H27F2N3O | 2368253-58-9 | Details |
| Product Total： Product Page： | ||||
| 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 | ||||